Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy and
estimated to become the second leading cause of cancer-related deaths by 2030. Although …

Intraductal papillary neoplasm of the bile duct (IPNB), a pre-invasive neoplasm of the bile
duct, is being established pathologically as a precursor lesion of invasive …

Recently discovered DNAJB1-PRKACA oncogenic fusions have been considered
diagnostic for fibrolamellar hepatocellular carcinoma. In this study, we describe six …

Due to the lack of timely and accurate screening modalities and treatments, most pancreatic
cancer (PCa) patients undergo fatal PCa progression within a short period since diagnosis …

Pancreatic ductal adenocarcinoma (PDA), one of the most lethal cancers worldwide, is
associated with two main types of morphologically distinct precursors—pancreatic …

Pancreatic cancer arises from noninvasive precursor lesions, including pancreatic
intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasm (IPMN), and …

Pancreatic ductal adenocarcinoma is one of the most aggressive malignant neoplasms with
poor outcomes. At the time of diagnosis, the disease is usually at an advanced stage and …

Background Different perspectives exist regarding the clinicopathologic characteristics,
biology and management of gallbladder polyps. Size is often used as the surrogate …

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest types of cancer
worldwide. There are many reasons for this dismal prognosis, including the advanced stage …

Pancreatic intraductal papillary mucinous neoplasms (IPMNs) have gained substantial
attention because they represent one of the only radiographically identifiable precursors of …